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ABSTRACT Communication between bacterial cells is crucial for the coordination of
diverse cellular processes that facilitate environmental adaptation and, in the case
of pathogenic species, virulence. This is achieved by the secretion and detection of
small signaling molecules called autoinducers, a process termed quorum sensing. To
date, the only signaling molecule recognized by both Gram-positive and Gram-
negative bacteria is autoinducer 2 (AI-2), synthesized by the metabolic enzyme LuxS
(S-ribosylhomocysteine lyase) as a by-product of the activated methyl cycle. Homo-
logues of LuxS are ubiquitous in bacteria, suggesting a key role in interspecies, as
well as intraspecies, communication. Gram-negative bacteria sense and respond to
AI-2 via the Lsr ABC transporter system or by the LuxP/LuxQ phosphorelay system.
However, homologues of these systems are absent from Gram-positive bacteria and
the AI-2 receptor is unknown. Here we show that in the major human pathogen
Streptococcus pneumoniae, sensing of exogenous AI-2 is dependent on FruA, a
fructose-speciﬁc phosphoenolpyruvate-phosphotransferase system that is highly con-
served in Gram-positive pathogens. Importantly, AI-2 signaling via FruA enables the
bacterium to utilize galactose as a carbon source and upregulates the Leloir path-
way, thereby leading to increased production of capsular polysaccharide and a hy-
pervirulent phenotype.
IMPORTANCE S. pneumoniae is a Gram-positive bacterium frequently carried asymp-
tomatically in the human nasopharynx. However, in a proportion of cases, it can
spread to other sites of the body, causing life-threatening diseases that translate
into massive global morbidity and mortality. Our data show that AI-2 signaling via
FruA promotes the transition of the pneumococcus from colonization to invasion by
facilitating the utilization of galactose, the principal sugar available in the upper re-
spiratory tract. AI-2-mediated upregulation of Leloir pathway enzymes results in in-
creased production of capsular polysaccharide and hypervirulence in a murine intra-
nasal challenge model. This identiﬁes the highly conserved FruA phosphotransferase
system as a target for new antimicrobials based on the disruption of this generic
quorum-sensing system.
Streptococcus pneumoniae (the pneumococcus) is one of the world’s foremost bac-terial pathogens, killing 1 to 2 million people each year. In spite of this, it is
considered part of the “normal” nasopharyngeal microﬂora, asymptomatically coloniz-
ing up to 95% of individuals. In a proportion of such carriers, pneumococci from this
mucosal beachhead can penetrate deeper tissues, causing a variety of diseases, includ-
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ing pneumonia, bacteremia, meningitis, and otitis media, which collectively inﬂict
massive global morbidity and mortality (1–3).
Although S. pneumoniae is probably one of the most studied bacterial pathogens,
the mechanism behind its transition from colonizer to pathogen remains a mystery. The
capacity to form a bioﬁlm on host mucosal surfaces is increasingly being recognized as
a critical event in the pathogenesis of pneumococcal disease (4). Within these com-
munities, bacteria exchange both metabolic signals and metabolizable factors, but they
can also communicate via a series of small diffusible autoinducer (AI) molecules that
speciﬁcally induce changes in gene expression in target cells in a density-dependent
fashion. Such interactions are grouped under the general term quorum-sensing (QS)
systems (5). QS systems enable bacteria to monitor their population density by releas-
ing AIs and subsequently responding to threshold concentrations of accumulated AIs.
QS systems can be divided into three major classes: (i) LuxI/LuxR-type QS in
Gram-negative bacteria, (ii) oligopeptide two-component QS in Gram-positive bacteria,
and (iii) LuxS-mediated AI-2 QS in both Gram-positive and Gram-negative bacteria
(6–9). The LuxS/AI-2 QS system is believed to function in interspecies communication
in polymicrobial communities, such as in the human nasopharynx. The synthesis of AI-2
is catalyzed by the metabolic enzyme LuxS, which generates the precursor com-
pound 4,5-dihydroxy-2,3-pentanedione (DPD) as a by-product of the conversion of
S-ribosylhomocysteine into homocysteine, an integral reaction of the activated methyl
cycle (10). Gram-negative bacteria such as Escherichia coli and Salmonella spp. sense
and respond to AI-2 via the Lsr ABC transporter system, while in Vibrio spp., a
furanosyl-borate-diester form of AI-2 is detected by the LuxP/LuxQ phosphorelay
system (11). However, homologues of these systems are absent from Gram-positive
bacteria and the AI-2 receptor is unknown.
DPD is essentially a pentose with two keto groups. Low-GC Gram-positive bacteria,
such as S. pneumoniae, are characterized by having a large array of carbohydrate
binding and transport proteins on their surface (12). These proteins are the prime
candidates for the binding of any extracellular sugars and are therefore also the likely
transporters for ketopentose sugars such as AI-2. S. pneumoniae has 30 sugar uptake
systems, including 21 phosphotransferase systems (PTS). These systems use phosphoe-
nolpyruvate as an energy source for the uptake of their substrates and as a phosphoryl
donor for their phosphorylation. The use of a PTS to transport AI-2 in pneumococci is
an attractive hypothesis, given that the incoming QS molecule would be phosphory-
lated, a modiﬁcation that is known to occur in Lsr-mediated AI-2 uptake in Gram-
negative species (13, 14). Phosphorylated AI-2 would be unable to cross the cell
membrane, enabling intracellular accumulation of AI-2-P in accordance with the extra-
cellular AI-2 concentration, thereby enabling a cell density-dependent response.
A previous study has suggested that the LuxS/AI-2 QS system is directly involved in
disease pathogenesis in many bacterial species (11). In a mouse intranasal (i.n.) chal-
lenge model, an S. pneumoniae luxS mutant was less able than wild-type strain D39 to
spread from the nasopharynx to the lungs or blood (15). The mutant also showed
defects in several in vitro virulence-related phenotypes, including the capacity to form
a bioﬁlm, iron uptake, and genetic competence (16). However, such studies with luxS
mutants alone cannot discriminate phenotypes dependent on AI-2 signaling from
general metabolic effects of interruption of the activated methyl cycle. In the present
study, we showed that exogenous AI-2 could complement defects in virulence-related
in vitro and in vivo phenotypes of luxS mutants and also identiﬁed the mechanism
whereby AI-2 modulates the virulence of S. pneumoniae.
RESULTS
Exogenous AI-2 complements luxS mutant growth phenotypes. The primary
habitat of S. pneumoniae is the human upper respiratory tract, where the principal
sugar available for use as a carbon source is galactose (17, 18). However, previous
studies of the growth properties of S. pneumoniae luxS mutants have employed media
that contain glucose, and no growth defects were reported (16, 19, 20). We therefore
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commenced by comparing the growth phenotypes of serotype 2 S. pneumoniae strain
D39 with that of its luxS deletion mutant (D39ΔluxS) and a luxS-overexpressing strain
(D39luxS) in CY medium (21) containing either glucose (CY-Glc) (Fig. 1A) or
galactose (CY-Gal) (Fig. 1B). In CY-Glc, the growth kinetics of D39 and D39ΔluxS
were virtually identical, while there was a slight growth retardation of the D39luxS
strain (Fig. 1A). In contrast, in CY-Gal, there was a marked increase in the generation
time and a reduction in the ﬁnal cell density of both D39ΔluxS and D39luxS compared
to those of the D39 parent strain (Fig. 1B). This suggested that either too little or too
much luxS expression may be detrimental in this medium. To distinguish between true
QS effects mediated by AI-2 from the indirect consequences of luxS disruption on the
activated methyl cycle, we then examined the capacity of various concentrations of
exogenous puriﬁed DPD (AI-2) to complement the growth defect of D39ΔluxS in
FIG 1 Impact of AI-2 on bacterial growth. D39, D39ΔluxS, and D39luxS were cultured in CY-Glc (A)
or CY-Gal (B), and growth was monitored by measuring the OD600. (C) The growth of D39 and D39ΔluxS
in CY-Gal supplemented with 0, 4, 10, or 200 M AI-2 was monitored. Data are mean values of triplicate
cultures.
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CY-Gal. Supplementation of CY-Gal with 10 M AI-2 partially restored growth, but
supplementation with lower (4 M) or higher (200 M) AI-2 concentrations had no
impact whatsoever (Fig. 1C). Furthermore, the growth defect of D39luxS in CY-Gal
could not be complemented by any of these concentrations of AI-2 (result not
presented). Taken together, these ﬁndings indicate that extracellular AI-2 is either
sensed or imported into the cell and that this process appears to be under carbon
catabolite repression.
Exogenous AI-2 increases S. pneumoniae virulence.We then determined whether
the known virulence defect of a luxS mutant relative to its wild-type parent D39 (15)
could be complemented by administration of exogenous synthetic AI-2. Mice were
challenged i.n. with S. pneumoniae D39, D39ΔluxS, or D39luxS with or without AI-2
administered i.n. at time zero and at 6, 12, and 18 h postinfection. Mice challenged with
D39ΔluxS had signiﬁcantly lighter bacterial loads in the nasopharynx, lungs, and blood
at 24 h postchallenge than those challenged with D39 (Fig. 2). However, i.n. adminis-
tration of AI-2 signiﬁcantly increased the bacterial loads in all host niches, such that the
virulence of D39ΔluxS with AI-2 was indistinguishable from that of D39 without AI-2,
while D39 with AI-2 became hypervirulent. In contrast, mice challenged with D39luxS
had signiﬁcantly lighter bacterial loads in the nasopharynx than D39-challenged mice
(Fig. 2A) and no bacteria could be detected in the lungs or blood of these mice.
Moreover, unlike the ﬁndings with D39- and D39ΔluxS-infected mice, i.n. administration
of AI-2 did not increase the numbers of D39luxS bacteria in any of the host niches
(Fig. 2A to C).
Histological analysis of the infected lungs at 12 h postinfection reﬂected the above
ﬁndings (Fig. 3A). Lungs from mice challenged with D39ΔluxS exhibited less severe
inﬂammation than those from mice challenged with D39, as evidenced by hematoxylin-
and-eosin (H&E)-stained sections, resulting in a lower mean pathological score (Fig. 3B).
Two out of three mice challenged with D39ΔluxS showed no or only mild inﬂammation
signs in the lung tissue (only a minor degree of swelling of alveolar/bronchiole walls
and minor lung tissue leukocyte inﬁltration), similar to those of uninfected mice
(Fig. 3A, D39ΔluxS panel). Importantly, AI-2 treatment of both D39- and D39ΔluxS-
infected mice increased the degree of inﬂammation, such that the lungs of mice
challenged with D39ΔluxS and treated with AI-2 were similar to those of mice chal-
lenged with D39, while the degree of inﬂammation in the lungs of mice challenged
with D39 and treated with synthetic AI-2 was higher than that of mice challenged with
D39. AI-2 treatment increased the mean pathological score of lungs challenged with
D39ΔluxS to 5.0, compared with 4.3 for those challenged with D39, while AI-2 treatment
of D39-challenged mice increased the mean pathological score to 7.0 (Fig. 3B).
As further conﬁrmation that exogenous AI-2 increases virulence, mice (n  5 per
group) challenged with D39 and treated with AI-2 as described above had a median
survival time of 53 h, compared to 73 h for those given phosphate-buffered saline (PBS)
(P  0.05; Mann-Whitney U test). Furthermore, at 48 h, the geometric mean bacterial
loads in the blood were 5.83  108 and 7.53  106 CFU/ml, respectively (P  0.01).
Thus, we conclude that the virulence defect of D39ΔluxS is attributable to loss of
AI-2 signaling rather than any metabolic side effect of perturbation of the activated
methyl cycle and that exogenous AI-2 directly increases virulence. The nonvirulent
phenotype observed in D39luxS and the lack of in vivo efﬁcacy of exogenous AI-2 in
this strain are consistent with the in vitro growth defect observed in CY-Gal, as well
as the inability of exogenous AI-2 to restore growth (Fig. 1C).
Bacterial loads in a given tissue type are determined not only by the growth rate but
also by the rate of clearance by innate immune cells. We therefore examined the
capacity of THP-1-derived human macrophages to internalize the various strains with or
without exogenous AI-2. The numbers of intracellular bacteria in macrophages infected
with D39ΔluxS and D39luxS were signiﬁcantly greater than (roughly double) that of
wild-type D39-infected cells (Fig. 4A). Preincubation of the bacteria with synthetic AI-2
signiﬁcantly decreased the ability of the macrophages to internalize D39 or D39ΔluxS,
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but there was no effect on the uptake of D39luxS (Fig. 4A). Thus, exogenous AI-2
signiﬁcantly increases the resistance of pneumococci to internalization by macro-
phages.
AI-2 promotes capsule production. In view of these ﬁndings, we hypothesized
that the stimulatory effects of exogenous AI-2 on virulence of S. pneumoniae D39, and
FIG 2 Exogenous AI-2 increases virulence of S. pneumoniae. Mice were challenged i.n. with 107 CFU of
D39, D39ΔluxS, or D39luxS with i.n. administration of 10 l of PBS with or without 1 g of AI-2 at 0, 6,
12, and 18 h postchallenge. Bacterial loads in the nasopharynx (A), blood (B), and lungs (C) were
determined at 24 h. Log-transformed data were analyzed by Student’s unpaired (two-tailed) t test: *,
P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
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the attenuating effect of luxS mutation, could be due to opposite impacts on capsular
polysaccharide (CPS) production, as the capsule is known to be strongly antiphagocytic
(22). Accordingly, we measured the total amount of type 2 CPS in cells grown in
CY-Glc or CY-Gal. Production of type 2 CPS was signiﬁcantly lower in the D39ΔluxS
and D39luxS strains than in wild-type D39 in CY-Gal (Fig. 4A), which is consistent
FIG 3 Histological examination. Mice were challenged i.n. with D39 or D39ΔluxS with or without AI-2 treatment
at 0 and 6 h. Lung sections from mice at 12 h after the i.n. challenge were stained with H&E and examined by light
microscopy (A) (scale bars are 0.05 mm). Lung sections were also scored according the following scheme:
congested capillaries (arrowheads), scored 0 to 2; thickened alveolar wall (hollow arrows), scored 0 to 2; secretion
and hemorrhage in the alveolar and bronchiolar spaces (solid arrows), scored 0 to 2; parenchymal hemorrhage
(dotted line) and neutrophil inﬁltration (arrows), scored 0 to 2. The total pathological score (maximum  8) is
shown for each mouse (n  3 per group) (B). A horizontal bar denotes the mean value of each group.
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with the attenuated virulence of these mutants. Moreover, exogenous AI-2 restored
CPS production by D39ΔluxS to a level commensurate with that of the wild type and
induced a signiﬁcant increase in CPS production by D39 (Fig. 4B), but again, AI-2 had
no effect on D39luxS. Thus, CPS production in vitro paralleled the hypervirulence of
D39 in the presence of exogenous AI-2 in vivo. However, when cells were grown in
CY-Glc, there were no signiﬁcant differences in either bacterial growth or CPS
FIG 4 Uptake by macrophages and total CPS production. (A) D39, D39ΔluxS, and D39luxS were
incubated with differentiated THP-1 cells after growth in CY-Gal with or without 10 M AI-2. Extra-
cellular bacteria were killed by penicillin and gentamicin treatment, and internalized pneumococci were
enumerated. Total CPS production by D39, D39ΔluxS, and D39luxS grown to an OD600 of 0.2 in CY-Gal
(B) or CY-Glc (C) with or without 10 M AI-2 was determined by uronic acid assay. Data are the mean the
standard deviation of triplicate assays and are expressed as a percentage of that for D39 without AI-2. Data
were analyzed by Student’s unpaired (two-tailed) t test: *, P  0.05; **, P  0.01; ***, P  0.001.
AI-2 Drives Pneumococcal Virulence via FruA ®















production among D39ΔluxS, D39luxS, and wild-type D39, and exogenous AI-2 had no
effect whatsoever (Fig. 4C). Moreover, the total CPS production by D39 in CY-Glc was
less than half of that seen in cells grown in CY-Gal (result not shown), consistent with
previous observations (23).
Global gene expression analysis of AI-2-treated cells. We then performed a
transcriptomic analysis to examine the global effect of exogenous AI-2 on gene
expression patterns in D39 and D39ΔluxS (Table 1). For these studies, cells were grown
in CY without added sugars and RNA was extracted 30 min after the addition of
10 M AI-2. Addition of AI-2 caused signiﬁcant changes in the expression of 22 genes
in D39 but only 9 genes in D39ΔluxS (adjusted P  0.05). Importantly, no differences in
the expression of any of the genes in the CPS biosynthesis (cps) locus were observed
in either strain. These data indicate that the impact of AI-2 on total CPS production, and
hence virulence, is independent of cps transcription. However, AI-2 did induce signiﬁ-
cant differences in the expression of four genes/operons in both strains, notably, an
operon (spd_0771-0773) comprising lacR1, fruB, and fruA (encoding the lactose phos-
TABLE 1 Differential gene expression in D39 relative to that in D39ΔluxS with or without AI-2a







SPD_0091 Conserved hypothetical protein 2.7 1.7
SPD_0114 Hypothetical protein 3.9
SPD_0115 Hypothetical protein 3.9
SPD_0116 Hypothetical protein 4.5
SPD_0117 Hypothetical protein 0.4
SPD_0265 adhA Alcohol dehydrogenase 0.7
SPD_0309 luxS LuxS S-ribosylhomocysteine lyase 0.0003
SPD_0334 aliA Oligopeptide-binding protein AliA 2.1
SPD_0404 ilvB Lactose phosphotransferase system repressor 1.7
SPD_0405 ilvN Acetolactate synthase 1.7
SPD_0406 ilvC Ketol-acid reductoisomerase 1.7
SPD_0407 Conserved hypothetical protein 1.8
SPD_0408 Conserved hypothetical protein 1.8
SPD_0420 pﬂB Formate acetyltransferase 0.4 0.6
SPD_0451 Type I restriction-modiﬁcation system 1.7
SPD_0546 brnQ Branched-chain amino acid transport system II
carrier protein
1.5 2.9 2.3
SPD_0558 prtA Cell wall-associated serine protease PrtA 0.5
SPD_0732 30S ribosomal protein 1.6
SPD_0771 lacR1 Lactose phosphotransferase system repressor 1.9 0.3 0.6
SPD_0772 fruB 1-Phosphofructokinase 1.9 0.3 0.5
SPD_0773 fruA PTS, fructose-speciﬁc IIABC components 1.7 0.4 0.7c
SPD_0900 asd Aspartate-semialdehyde dehydrogenase 1.6
SPD_0901 dapA Dihydrodipicolinate synthase 1.6
SDP_1004 gapN Glyceraldehyde-3-phosphate dehydrogenase 0.6
SPD_1256 Peptidase, U32 family protein 0.6
SPD_1257 Conserved hypothetical protein 0.6
SPD_1258 Peptidase, U32 family protein 0.6
SPD_1360 Conserved hypothetical protein 1.7
SPD_1408 Conserved hypothetical protein 1.8 1.7
SPD_1415 Oxidoreductase, pyridine nucleotide-disulﬁde 1.5
SPD_1504 nanA Sialidase A (neuraminidase A) 0.5
SPD_1563 dctA Serine/threonine transporter SstT 1.6
SPD_1649 piuA Iron compound ABC transporter 1.6 2.0 1.6
SPD_1650 Iron compound ABC transporter 1.5
SPD_1834 adhE Bifunctional acetaldehyde-coenzyme A/alcohol
dehydrogenase
2.0 0.1 0.1
SPD_1956 ilvD Dihydroxy-acid dehydratase 0.6
SPD_2012 glpO Alpha-glycerophosphate oxidase 1.7
SPD_2013 glpK Glycerol kinase 1.6
aDifferential gene expression was determined by RNA-seq analysis as described in Materials and Methods. Data shown are fold changes in gene expression for the
comparisons indicated. Genes commonly differentially expressed in all three comparisons are shown in bold type. Only genes with statistically signiﬁcant differential
expression (adjusted P  0.05) are shown, except where indicated otherwise.
bORF, open reading frame.
cNo statistically signiﬁcant differential expression.
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photransferase system repressor, phosphofructokinase, and fructose PTS enzyme IIABC,
respectively), piuA (iron-binding lipoprotein), adhE (an iron-containing aldehyde-
alcohol dehydrogenase), and brnQ (branched-chain amino acid transport system II
carrier) (Table 1). The differential expression of these genes was conﬁrmed by real-time
quantitative reverse transcription (qRT)-PCR analysis (Fig. 5). Interestingly, in both D39
and D39ΔluxS, fruA and adhE were repressed in the presence of AI-2 whereas brnQ and
piuA were induced. However, the transcription of all four genes was lower in D39ΔluxS
than in D39.
We therefore constructed D39 derivatives with deletion mutations in the four
AI-2-regulated genes identiﬁed above to determine whether any play a direct role in
AI-2 sensing by S. pneumoniae. The fruA gene was a particularly promising candidate,
as it encodes a fructose-PTS uptake system component that might be capable of
recognizing a ketopentose like AI-2. Moreover, PTS uptake systems typically phosphor-
ylate their cargo, resulting in intracellular retention and accumulation, a critical feature
of cell density-dependent signaling molecules such as AI-2 (12). In the ﬁrst instance, we
used CPS production in CY-Gal as a readout of AI-2-mediated signaling. Similar to the
earlier observations for D39 and D39ΔluxS, exogenous AI-2 increased the total CPS in
D39ΔpiuA and D39ΔadhE. Strikingly, AI-2 had no impact whatsoever on CPS production
by D39ΔfruA (Fig. 6). Moreover, when tested in the murine i.n. challenge model (n  5
per group), D39ΔfruA was at least as virulent as D39, but importantly, treatment with
exogenous AI-2 had no effect on the loads of D39ΔfruA bacteria in the nasopharynx,
blood, and lungs at 24 h postchallenge. Respective geometric mean bacterial loads in
the absence or presence of AI-2 were 7.94  103 versus 1.10  104 CFU in the
nasopharynx, 4.07  105 versus 1.55  105 CFU/ml in the blood, and 7.11  105 versus
1.20  105 CFU in the lungs. However, the impact of the brnQ deletion on CPS
FIG 5 Relative expression of fruA, adhE, spd_0546, and piuA by D39 and D39ΔluxS grown in CY with or
without 10 M AI-2 was quantitated by qRT-PCR with 16S rRNA as an internal standard. Data are total
expression relative to 16S rRNA (mean  the standard deviation of three independent experiments). *, P 
0.05; **, P  0.01; ***, P  0.001 (Student’s unpaired t test).
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production could not be assessed in the D39ΔbrnQ strain because of a major in vitro
growth defect.
Collectively, the above ﬁndings indicate that AI-2 signaling in S. pneumoniae is
dependent on FruA and suggest that the impacts on growth, CPS production, and
virulence may be mediated via effects on Gal uptake and/or catabolism. In S. pneu-
moniae, there are two pathways for Gal uptake and utilization: a PTS (SPD_0559-0561)
whereby Gal-6-phosphate (Gal6P) is fed into the glycolytic pathway via the tagatose-
6-phosphate pathway and a Gal-speciﬁc ABC transporter (SPD_0088-0090) that delivers
free Gal into the Leloir pathway. The latter pathway is critically important, as it
generates Glc-1-phosphate (G1P), from which various UDP-activated sugar precursors
required for CPS synthesis are derived (18, 23). We therefore examined the transcription
of spd_0088 and Leloir pathway genes galR (transcriptional regulator), galK (galactoki-
nase), and galT (galactose-1-phosphate uridyltransferase), as well as lacD (tagatose
1,6-diphosphate aldolase, the last enzyme of the tagatose-6-phosphate pathway), in
D39 and D39ΔluxS grown in a fully synthetic chemically deﬁned medium (CDM) (24)
with Gal as the sole carbon source (CDM-Gal) with or without 10 M AI-2. Transcription
of cps2A, the ﬁrst gene of the locus encoding type 2 CPS biosynthesis, was also
assessed. No differences in cps2A transcription between D39 and D39ΔluxS were seen,
with or without AI-2 in CDM-Gal, consistent with the previous RNA-seq data (result not
shown). However, the expression of galR, galK, and galT was signiﬁcantly lower in
D39ΔluxS than in D39. Moreover, addition of AI-2 signiﬁcantly increased the expression
of all three genes in both strains. Indeed, exogenous AI-2 increased the expression of
the Leloir pathway genes in D39ΔluxS such that it was essentially identical to that in
D39 without added AI-2, thereby fully complementing the luxS mutation (Fig. 7B to D).
Expression of the Gal ABC transporter spd_0088 gene showed a trend identical to that
of the Leloir pathway genes, but the differences did not reach statistical signiﬁcance
(Fig. 7A). However, the tagatose pathway gene lacD did not respond to exogenous AI-2
in either strain (Fig. 7E). Interestingly, unlike the ﬁndings in medium without added
sugars (Fig. 5), in CDM-Gal, expression of fruA by D39 and D39ΔluxS in response to AI-2
mirrored that of the Leloir pathway genes (Fig. 7F). Importantly, in D39ΔfruA, AI-2 had
no effect whatsoever on the expression of Leloir pathway genes galR, galK, or galT or
of spd_0088 (Fig. 7A to D). Thus, FruA is essential for the transcriptional response of
galactose uptake and utilization genes to exogenous AI-2 that results in upregulation
of CPS production and increased virulence. It is important to note that FruA itself plays
no known catalytic role in Gal uptake or catabolism or CPS synthesis. Thus, our ﬁndings
that the baseline Leloir pathway gene expression, total CPS production, and virulence
of D39ΔfruA are similar to or even higher than those of D39 do not conﬂict with the
hypothesis that FruA transduces the AI-2 signal.
FIG 6 CPS production by D39ΔadhE, D39ΔpiuA, and D39ΔfruA after growth in CY-Gal to an OD600 of
0.2 with or without 10 M AI-2 was determined by uronic acid assay. Data are the mean  the standard
deviation of triplicate assays and are expressed as a percentage of D39 without AI-2. *, P  0.05; **, P 
0.01 (Student’s unpaired t test).
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In order to account for the lower CPS production and avirulence of the luxS-
overexpressing strain observed in Fig. 2 and 4, we then examined spd_0088, galT, and
fruA expression in D39luxS versus D39 (Fig. 8). In D39, all three genes were signiﬁ-
cantly upregulated in the presence of exogenous AI-2. However, all three genes were
signiﬁcantly downregulated in D39luxS relative to D39 and expression did not in-
crease in the presence of AI-2. These ﬁndings further illustrate the tight nexus between
galactose uptake/catabolism and CPS production. These data also indicate that there is
an optimum AI-2 concentration range above which responses to the QS molecule are
switched off. This was further examined by measuring spd_0088 and galT expression in
D39 and D39ΔluxS exposed to higher AI-2 concentrations. In D39, addition of 60 M
AI-2 upregulated spd_0088 and galT, but these genes were signiﬁcantly downregulated
at 80 and 120 M AI-2, respectively (Fig. 9). In D39ΔluxS, exogenous AI-2 remained
stimulatory at concentrations of up to 120 M, but signiﬁcant downregulation occurred
at 200 M. This higher inhibitory threshold is presumably attributable to the absence
of baseline endogenous AI-2 synthesis in the luxS mutant.
FIG 7 Relative expression of spd_0088 (A), galR (B), galK (C), galT (D), lacD (E), and fruA (F) by D39,
D39ΔluxS, and D39ΔfruA grown in CDM-Gal with or without 10 M AI-2 was quantitated by qRT-PCR with
16S rRNA as an internal standard as described in Materials and Methods. Data are the total expression
relative to 16S rRNA (mean  the standard deviation from three independent experiments). *, P  0.05;
**, P  0.01 (Student’s unpaired t test).
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AI-2 released by LuxS activity has been recognized as a universal language for
bacterial communication (25). However, there has been uncertainty as to whether the
LuxS/AI-2 system has a true QS function in Gram-positive bacteria or just a metabolic
role as a component of the activated methyl cycle. Lack of any knowledge of the AI-2
receptor in Gram-positive bacteria has also hindered investigations of how AI-2 signals
are transduced in these organisms. In S. pneumoniae, the effects of luxS deletion include
reduced bioﬁlm formation and virulence, as well as effects on genetic competence and
fratricide (16, 19, 26). Thus, luxS appears to lie at the center of a complex QS regulatory
network (11, 27, 28). Recent availability of synthetic DPD, which spontaneously cyclizes
to form biologically active AI-2 (29), has enabled experimental complementation of luxS
FIG 8 Relative expression of spd_0088 (A), galT (B), and fruA (C) by D39 and D39luxS grown in CDM-Gal
with or without 10 M AI-2 was quantitated by qRT-PCR with 16S rRNA as an internal standard. Data are
the total expression relative to 16S rRNA (mean  the standard deviation of three independent
experiments). *, P  0.05; **, P  0.01 (Student’s unpaired t test).
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mutant phenotypes. In the present study, we have used synthetic AI-2 to complement
defects in pneumococcal growth and CPS production in vitro in media containing Gal,
as well as defects in virulence seen in D39ΔluxS in a murine i.n. challenge model. These
ﬁndings conﬁrm that LuxS/AI-2 is a functional QS system in pneumococci.
Our ﬁndings also highlight the importance of Gal utilization by pneumococci in vivo.
This sugar is the dominant carbon source available to pneumococci in the upper
respiratory tract, where Glc is in very low abundance (30, 31). This Gal is largely derived
from host glycoconjugates by the sequential action of NanA (neuraminidase) and Bga
(-galactosidase) (32, 33). Although D39ΔluxS grew normally in CY-Glc, there was a
major growth defect in CY-Gal that was complemented with exogenous AI-2. These
ﬁndings paralleled in vivo bacterial loads in the murine model, where the capacity to
colonize the nasopharynx and spread to deeper tissues was attenuated in D39ΔluxS
unless exogenous AI-2 was provided. Further in vitro studies showed that luxSmutation
diminished resistance to phagocytosis by macrophages, while addition of AI-2 en-
hanced such resistance in both D39 and D39ΔluxS. Effects of luxS mutation and AI-2
FIG 9 Relative expression of spd_0088 (A) and fruA (B) by D39 and D39ΔluxS grown in CDM-Gal. D39 and
D39ΔluxS were treated with 0, 60, 80, 120, or 200 M AI-2, and transcripts were quantitated by qRT-PCR
with 16S rRNA as an internal standard. Data are total expression relative to 16S rRNA (mean  the
standard deviation from three independent experiments). *, P  0.05; **, P  0.01; ***, P  0.001; ****,
P  0.0001 (Student’s unpaired t test).
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treatment on the above in vitro and in vivo parameters were entirely consistent with
differences in total CPS production in CY-Gal.
Despite the above observations, transcriptomic analyses showed no signiﬁcant
differences in the expression of any of the genes in the CPS biosynthesis locus, nor were
there any differences in cps2A transcription, as judged by qRT-PCR. However, our data
show that AI-2-mediated effects on CPS production could be driven by the availability
of activated sugar precursors for CPS biosynthesis. Exogenous AI-2 upregulated genes
encoding the Gal ABC transporter Spd_0088 and enzymes of the Leloir pathway (GalR,
GalK, and GalT) in both D39 and D39ΔluxS, and the expression of all of these genes was
lower in D39ΔluxS than in D39. When Gal is the only available sugar, as predominantly
occurs in the respiratory tract, this is the only pathway capable of generating G1P, from
which various UDP-activated sugar precursors required for CPS synthesis are derived
(18, 23). The only other known Gal uptake system in S. pneumoniae is a PTS-like system
that imports Gal as Gal-6-P. This can feed into the glycolytic pathway via the tagatose-
6-P pathway, but it cannot be used to directly generate CPS precursors (23).
Since it has been shown that AI-2 acts as a QS signaling molecule that upregulates
CPS production and virulence in S. pneumoniae, this then leads to the logical question
of how the signal itself is transduced. In Gram-negative bacteria such as E. coli and
Salmonella spp., AI-2 is imported by the Lsr transport system, which is repressed in the
absence of an AI-2 signal by LsrR. When AI-2 is present, it is phosphorylated by LsrK,
which relieves LsrR repression, activating the Lsr operon, and massively amplifying AI-2
internalization via the LsrABCD permease complex (34). It has been suggested that the
purpose of this is to deplete the external environment of AI-2, thereby denying other
bacteria in the niche, e.g., the gut, of a QS signal. However, the actual AI-2-mediated QS
event that sets this cascade in motion involves a PTS that delivers AI-2 to LsrK. Mutation
of ptsI, which encodes the enzyme I component common to multiple PTS uptake
systems, prevents internalization of AI-2 and its phosphorylation by LsrK. However, the
identity of the individual PTS permease that internalizes AI-2 remains unknown, and no
single mutation in any of the known PTS permeases is capable of blocking Lsr-mediated
uptake completely (34).
Gram-positive bacteria lack any homologues of either the Lsr permease or the
LuxP/LuxQ phosphorelay system that internalizes AI-2 in Vibrio spp. (35). However, in
the present study, we have shown unequivocally that the fructose PTS component
IIABC FruA is necessary for AI-2 signaling in S. pneumoniae. D39ΔfruA cannot respond
to exogenous AI-2, as indicated by lack of induction of spd_0088, galR, galK, or galT.
Furthermore, there was no increase in total CPS production or virulence when
D39ΔfruA was treated with AI-2 either in vitro or in vivo. FruA was identiﬁed as a
candidate AI-2 receptor, as fruA was one of only four genes/operons whose expression
level changed in both D39 and D39ΔluxS on exposure to AI-2, as judged by transcrip-
tomic analyses. Mutation of two of the other genes (piuA and adhE) had no impact on
AI-2 signaling, while mutation of the remaining AI-2-responsive gene (brnQ) had
pleiotropic impacts that rendered the mutant incapable of growth in the CDM used in
our transcriptional studies. Regulation of a sensor by its cognate ligand is an essential
feature of a true QS system. In this context, it is interesting that expression of the fruA
homologue in Staphylococcus epidermidis has also been shown to respond to exoge-
nous AI-2 (36).
Here, we propose a model of the modulation of pneumococcal virulence by AI-2
whereby pneumococci establishing colonization of the human nasopharynx may ini-
tially be present at a low density but are able to sense AI-2 in the external environment
released by themselves and by other commensal nasopharyngeal microorganisms.
Recognition and import of AI-2 by the FruA PTS would both internalize AI-2 and
perhaps phosphorylate it to form AI-2-P, which then would no longer be able to cross
the membrane, trapping it within the cell. We attempted to detect AI-2-P by 2H nuclear
magnetic resonance analysis of D39 and D39ΔluxS cell extracts before and after
exposure to exogenous AI-2 but were not successful. Nevertheless, our data clearly
show that AI-2 upregulates the Gal ABC transporter and the Leloir pathway enzymes,
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which are under the control of GalR, which is also upregulated by AI-2. It is tempting
to speculate that AI-2-P is capable of phosphorylating GalR, thereby directly activating
(or relieving repression of) the gal operon. In S. pneumoniae, GalR is known to be
phosphorylated at residues S317, T319, and T323 (37). Thus, mutational analysis of
these GalR residues in D39 may be informative. Regardless of the precise molecular
mechanism, the above events would confer the capacity to import free Gal into the
respiratory tract, enabling its utilization as a carbon source in general and for synthesis
of CPS precursors in particular. Increased CPS production would, in turn, enhance
resistance to phagocytosis and increase the capacity of the pneumococcus to invade
deeper tissues.
Our ﬁndings provide strong evidence implicating FruA as a receptor/transporter for
AI-2 in S. pneumoniae. While further studies are required, FruA is unequivocally essential
for transduction of AI-2-mediated signaling. FruA is highly conserved among Gram-
positive bacteria and may therefore represent a target for novel antimicrobials that
would attenuate colonization and interfere with disease progression. Such agents
would not be expected to be bactericidal and so may have a lesser impact on the
microbial ecology of the host and also not apply selective pressure for evolution of
resistance.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The S. pneumoniae strains used in this study are listed in
Table 2. Strains were routinely cultured on Columbia blood agar base supplemented with 5% horse
blood at 37°C in 95% air–5% CO2. Blood agar plates were supplemented with 0.2 g/ml erythromycin or
200 g/ml spectinomycin for the selection of mutant strains. Growth experiments with pneumococci in
liquid culture were performed with a casein-based semisynthetic medium (CY) (21). For animal
challenge experiments, pneumococci were grown in nutrient broth supplemented with 10% (vol/vol)
horse serum. Gene expression experiments were performed with a CDM (38) supplemented with catalase
(10 U/ml; Sigma) at 37°C under static conditions. The AI-2 precursor molecule, DPD, was purchased from
Omm Scientiﬁc Inc., TX.
Construction of mutant strains. Genes were deleted from S. pneumoniae D39 and replaced with an
erythromycin or spectinomycin resistance cassette by transformation with a linear DNA fragment
constructed by overlap extension PCR (39) with primers listed in Table 3.
Growth assays. Analysis of pneumococcal growth was performed in 96-well microtiter plates (200-l
culture volume) at 37°C. Culture optical density at 600 nm (OD600) was measured at 30-min intervals over
a 24-h time period with a Spectromax spectrophotometer (Molecular Devices).
Murine infection model. Our animal experiments were approved by the University of Adelaide
Animal Ethics Committee. Female outbred 4- to 6-week-old CD-1 (Swiss) mice were anesthetized and
inoculated i.n. with 107 CFU of wild-type D39, D39ΔluxS, or D39luxS in 50 l of medium as described
previously (40). Two groups of ﬁve mice were used for each strain tested, and at time zero and 6, 12, and
18 h postinfection, one group received 1 g of AI-2 in 10 l of PBS i.n. (without anesthesia), while the
other group received 10 l of PBS as a control. Nasal wash, nasopharyngeal tissue, lung, and blood
samples were collected and processed as previously described at 24 h postinfection. Samples were
homogenized where appropriate, serially diluted, and plated onto blood agar for enumeration of viable
pneumococci as previously described (40, 41). Statistical analyses of log-transformed data were per-
formed with a two-tailed Student t test; a P value of 0.05 was deﬁned as statistically signiﬁcant.
Histological examination of lung tissue. Twelve hours after an i.n. challenge or no challenge
(control), lungs were removed from euthanized mice, ﬁxed in 4% formaldehyde overnight at 4°C,
embedded in parafﬁn, sectioned, stained with H&E, and examined by light microscopy (Axiophot; Zeiss,
Germany). Digital images were captured and processed with a CCIZ soft imaging system and analySIS LS
Research software. Lung pathological scores (maximum  8) for each mouse were determined by a
blinded observer according the following scheme: congested capillaries, scored 1 to 2; thickened alveolar
wall, scored 1 to 2; secretions and hemorrhage in alveolar and bronchiolar spaces, scored 1 to 2;
parenchymal hemorrhage and neutrophil inﬁltration, scored 1 to 2.
TABLE 2 S. pneumoniae strains used in this study
Strain Description Source or reference
D39 Capsular serotype 2 NCTC 7466
D39ΔluxS luxS deletion-replacement mutant (Specr) This study
D39ΔfruA fruA deletion-replacement mutant (Specr) This study
D39ΔadhE adhE deletion-replacement mutant (Specr) This study
D39luxS D39 carrying pALT2::luxS 16
D39ΔpiuA piuA deletion-replacement mutant (Eryr) 47
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Culture and differentiation of THP-1 cells and phagocytic assay. All tissue culture media and
reagents were obtained from Gibco. THP-1 cells (ATCC TIB-202) were grown in 95% air–5% CO2 at 37°C
in complete RPMI medium (RPMI with phenol red, supplemented with 10% fetal calf serum, 10 mM
HEPES, 50 IU/ml penicillin, and 50 g/ml streptomycin). Ten-centimeter dishes were seeded with 3.5 
106 THP-1 cells and differentiated by adding phorbol 12-myristate 13-acetate to a ﬁnal concentration of
10 ng/ml and incubating them for 3 days at 37°C in 95% air–5% CO2. Differentiated cells attach to the
plastic surface. Following the 3 days of incubation, cells were washed twice with complete RPMI and then
rested at 37°C in 95% air–5% CO2 in complete RPMI for a further 3 days. At 90% conﬂuence, differentiated
THP-1 cells were incubated with bacteria (100 l) at a 10:1 ratio of bacteria to THP1 cells. After 45 min,
plates were washed and cells were reincubated with 10 g/ml penicillin and 200 g/ml gentamicin
(Sigma, Germany) for 30 min to kill extracellular pneumococci. Intracellular bacteria were enumerated
after lysis with 0.01% Triton X-100 by plating serial dilutions on blood agar.
Uronic acid assay. Pneumococcal CPS samples were prepared as previously described (42). In brief,
deoxycholate-lysed pneumococci were treated by adding 100 U of mutanolysin (Sigma, Australia), 50 U
of DNase I (Roche, Australia), and 50 g of RNase A, incubating them overnight at 37°C, and treating
them with 100 g/ml proteinase K at 56°C for 4 h. Uronic acid was then quantitated colorimetrically as
described previously (42).
Bacterial RNA extraction and RNA-seq analysis. S. pneumoniae strains were grown in CY without
added sugars to an OD600 of 0.15 and then treated with or without 10 M AI-2 for 30 min. RNA extraction
was performed with a Qiagen RNase minikit according the manufacturer’s protocol. Each sample was
derived from three independent cultures (biological replicates) and pooled prior to transcriptome
sequencing (RNA-seq) analysis. Total RNA was submitted to the Australian Genome Research Facility
(Melbourne, Australia) for sequencing. Brieﬂy, the Epicentre Bacterial Ribozero kit (Illumina) was used to
reduce the rRNA content, and then the Ultra Directional RNA kit (New England Biolabs) was used to
generate bar-coded libraries. Prepared libraries were then sequenced with the Illumina HiSeq 2500.
Trimmed RNA-seq fastq ﬁles were then mapped to the D39 reference genome with BOWTIE2 version
2.2.3 (43). Counts for each gene were obtained with the aid of BEDTools (44), and differential gene
expression was examined with DESeq (45).
Real-time qRT-PCR. For qRT-PCR analyses, cells were grown in CDM-Gal to an OD600 of 0.2 and
treated with or without 10 M AI-2 for 30 min. RNA was extracted from triplicate cultures as described
above, but individual rather than pooled extracts were analyzed. Gene expression was assayed by






















SPD0546 spec for AAATAACAGATTGAAGAAGGTATAATGAAATGGAATAATCACTAAT
SPD0546 spec Rev TATGTATTCATATATATCCTCCCTTTTTTAGCCATAAAAATCTCCT
luxS for TGGACCAGCCCTAGCCTTTGAA
luxS Rev CACACTTGACTAAGGAAGAC
luxS spec for AAATAACAGATTGAAGAAGGTATAATCTCACACCACCGTACGTA
luxS spec Rev TATGTATTCATATATATCCTCCTCGTTGCTCCTGAGACAGA
adhE for GAGATTCCTTATGACAAGAA
adhE Rev TACTAGCTTATTATTCTAG
adhE spec for AAATAACAGATTGAAGAAGGTATAATGTTTATCAGTCTAGAAG
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one-step relative real-time qRT-PCR in a Roche LC480 real-time cycler essentially as described previously
(40). The speciﬁc primers used for the various genes are listed in Table 3, and they were used at a ﬁnal
concentration of 200 nM. As an internal control, primers speciﬁc for 16S rRNA were employed. Ampli-
ﬁcation data were analyzed by the comparative critical threshold (2ΔΔCT) method (46) and are presented
as total expression relative to that of the 16S rRNA gene.
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